IHS Chemical Week

Regions :: North America :: U.S.

Perrigo to acquire Irish biotechnology company Elan for $8.6 billion

1:41 AM MDT | July 29, 2013 | Deepti Ramesh

Health-care products firm Perrigo (Allegan, MI) and biotechnology company Elan (Dublin) say that they have entered into a definitive agreement under which Perrigo will acquire Elan for about $8.6 billion. At the close of the transaction, Perrigo and Elan will be combined under New Perrigo, a new company incorporated in Ireland. New Perrigo, which is expected to be called Perrigo Co. or a variant thereof, will be led by Perrigo’s current leadership team. The proposed transaction, which has been unanimously approved by the respective boards of directors of...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa